F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Diabetic cardiomyopathy

Page 1 of 1 ( 37 items )
<<
1
>>

1	Is the cellular attribution of liraglutide action in diabetic cardiomyopathy conclusive? 7/9/2026 6:58:25 AM \| Browse: 17 \| Download: 23
2	Regulation of ferroptosis and mitochondrial homeostasis disruption in diabetic cardiomyopathy: Therapeutic potential of traditional Chinese medicine 7/9/2026 6:58:20 AM \| Browse: 7 \| Download: 4
3	Farrerol and the miR-29b-3p/sirtuin 1 pathway: A mechanistic breakthrough in protecting the diabetic heart 2/6/2026 8:43:33 AM \| Browse: 90 \| Download: 271
4	Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy 1/14/2026 8:09:14 AM \| Browse: 142 \| Download: 308
5	Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component? 1/14/2026 8:09:13 AM \| Browse: 102 \| Download: 308
6	Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway 12/15/2025 9:46:09 AM \| Browse: 125 \| Download: 585
7	Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy 12/15/2025 9:46:06 AM \| Browse: 129 \| Download: 304
8	Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study 10/15/2025 9:03:23 AM \| Browse: 123 \| Download: 501
9	Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography 10/15/2025 9:03:21 AM \| Browse: 155 \| Download: 401
10	Farrerol ameliorates diabetic cardiomyopathy by inhibiting ferroptosis via miR-29b-3p/SIRT1 signaling pathway in endothelial cells 9/11/2025 9:41:58 AM \| Browse: 323 \| Download: 711
11	Ferroptosis: A novel therapeutic target for diabetic cardiomyopathy 6/13/2025 11:47:55 AM \| Browse: 222 \| Download: 645
12	Double-edged sword of L-arginine in diabetes: Exploring anti-inflammatory and antioxidant strategies 2/28/2025 10:47:24 AM \| Browse: 350 \| Download: 656
13	Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure 1/21/2025 6:56:34 AM \| Browse: 230 \| Download: 625
14	Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management 11/26/2024 9:16:41 AM \| Browse: 121 \| Download: 629
15	Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies 11/18/2024 3:30:39 AM \| Browse: 219 \| Download: 704
16	Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy 9/26/2024 8:51:02 AM \| Browse: 233 \| Download: 932
17	Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy 9/26/2024 8:51:01 AM \| Browse: 278 \| Download: 914
18	Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy? 8/27/2024 3:11:19 PM \| Browse: 280 \| Download: 887
19	Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure 8/26/2024 12:59:17 PM \| Browse: 93 \| Download: 487
20	Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis 7/26/2024 6:56:09 AM \| Browse: 237 \| Download: 731
21	Diabetic cardiomyopathy: Emerging therapeutic options 7/26/2024 6:56:09 AM \| Browse: 302 \| Download: 680
22	Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy 6/11/2024 2:35:35 PM \| Browse: 192 \| Download: 827
23	Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome 4/12/2024 1:04:39 AM \| Browse: 186 \| Download: 1465
24	Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway 12/14/2023 9:36:12 AM \| Browse: 332 \| Download: 1681
25	Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization 12/14/2023 9:36:12 AM \| Browse: 442 \| Download: 1404
26	Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid 12/14/2023 9:36:11 AM \| Browse: 392 \| Download: 1134
27	Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology 11/14/2023 6:13:55 AM \| Browse: 434 \| Download: 1558
28	Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy 5/13/2022 10:36:57 AM \| Browse: 766 \| Download: 1863
29	Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury 4/14/2022 11:27:05 AM \| Browse: 756 \| Download: 2217
30	Role of novel biomarkers in diabetic cardiomyopathy 6/4/2021 1:47:10 PM \| Browse: 844 \| Download: 2018
31	Diabetic heart disease: A clinical update 4/9/2021 5:27:04 AM \| Browse: 856 \| Download: 1990
32	Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date 10/15/2019 3:36:45 AM \| Browse: 1081 \| Download: 1698
33	Trace elements in diabetic cardiomyopathy: An electrophysiological overview 9/1/2014 3:13:00 PM \| Browse: 1451 \| Download: 1444
34	Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management 9/1/2014 3:02:00 PM \| Browse: 1292 \| Download: 1328
35	Cardiac autonomic neuropathy in patients with diabetes mellitus 9/1/2014 12:00:00 PM \| Browse: 1795 \| Download: 1749
36	Is diabetic cardiomyopathy a specific entity? 8/27/2014 5:24:00 PM \| Browse: 1111 \| Download: 1225
37	Mechanisms underlying the impaired contractility of diabetic cardiomyopathy 8/22/2014 2:47:00 PM \| Browse: 1238 \| Download: 1374

Page 1 of 1 ( 37 items )
<<
1
>>

1	Is the cellular attribution of liraglutide action in diabetic cardiomyopathy conclusive? 7/9/2026 6:58:25 AM \| Browse: 17 \| Download: 23
2	Regulation of ferroptosis and mitochondrial homeostasis disruption in diabetic cardiomyopathy: Therapeutic potential of traditional Chinese medicine 7/9/2026 6:58:20 AM \| Browse: 7 \| Download: 4
3	Farrerol and the miR-29b-3p/sirtuin 1 pathway: A mechanistic breakthrough in protecting the diabetic heart 2/6/2026 8:43:33 AM \| Browse: 90 \| Download: 271
4	Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy 1/14/2026 8:09:14 AM \| Browse: 142 \| Download: 308
5	Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component? 1/14/2026 8:09:13 AM \| Browse: 102 \| Download: 308
6	Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway 12/15/2025 9:46:09 AM \| Browse: 125 \| Download: 585
7	Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy 12/15/2025 9:46:06 AM \| Browse: 129 \| Download: 304
8	Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study 10/15/2025 9:03:23 AM \| Browse: 123 \| Download: 501
9	Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography 10/15/2025 9:03:21 AM \| Browse: 155 \| Download: 401
10	Farrerol ameliorates diabetic cardiomyopathy by inhibiting ferroptosis via miR-29b-3p/SIRT1 signaling pathway in endothelial cells 9/11/2025 9:41:58 AM \| Browse: 323 \| Download: 711
11	Ferroptosis: A novel therapeutic target for diabetic cardiomyopathy 6/13/2025 11:47:55 AM \| Browse: 222 \| Download: 645
12	Double-edged sword of L-arginine in diabetes: Exploring anti-inflammatory and antioxidant strategies 2/28/2025 10:47:24 AM \| Browse: 350 \| Download: 656
13	Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure 1/21/2025 6:56:34 AM \| Browse: 230 \| Download: 625
14	Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management 11/26/2024 9:16:41 AM \| Browse: 121 \| Download: 629
15	Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies 11/18/2024 3:30:39 AM \| Browse: 219 \| Download: 704
16	Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy 9/26/2024 8:51:02 AM \| Browse: 233 \| Download: 932
17	Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy 9/26/2024 8:51:01 AM \| Browse: 278 \| Download: 914
18	Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy? 8/27/2024 3:11:19 PM \| Browse: 280 \| Download: 887
19	Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure 8/26/2024 12:59:17 PM \| Browse: 93 \| Download: 487
20	Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis 7/26/2024 6:56:09 AM \| Browse: 237 \| Download: 731
21	Diabetic cardiomyopathy: Emerging therapeutic options 7/26/2024 6:56:09 AM \| Browse: 302 \| Download: 680
22	Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy 6/11/2024 2:35:35 PM \| Browse: 192 \| Download: 827
23	Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome 4/12/2024 1:04:39 AM \| Browse: 186 \| Download: 1465
24	Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway 12/14/2023 9:36:12 AM \| Browse: 332 \| Download: 1681
25	Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization 12/14/2023 9:36:12 AM \| Browse: 442 \| Download: 1404
26	Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid 12/14/2023 9:36:11 AM \| Browse: 392 \| Download: 1134
27	Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology 11/14/2023 6:13:55 AM \| Browse: 434 \| Download: 1558
28	Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy 5/13/2022 10:36:57 AM \| Browse: 766 \| Download: 1863
29	Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury 4/14/2022 11:27:05 AM \| Browse: 756 \| Download: 2217
30	Role of novel biomarkers in diabetic cardiomyopathy 6/4/2021 1:47:10 PM \| Browse: 844 \| Download: 2018
31	Diabetic heart disease: A clinical update 4/9/2021 5:27:04 AM \| Browse: 856 \| Download: 1990
32	Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date 10/15/2019 3:36:45 AM \| Browse: 1081 \| Download: 1698
33	Trace elements in diabetic cardiomyopathy: An electrophysiological overview 9/1/2014 3:13:00 PM \| Browse: 1451 \| Download: 1444
34	Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management 9/1/2014 3:02:00 PM \| Browse: 1292 \| Download: 1328
35	Cardiac autonomic neuropathy in patients with diabetes mellitus 9/1/2014 12:00:00 PM \| Browse: 1795 \| Download: 1749
36	Is diabetic cardiomyopathy a specific entity? 8/27/2014 5:24:00 PM \| Browse: 1111 \| Download: 1225
37	Mechanisms underlying the impaired contractility of diabetic cardiomyopathy 8/22/2014 2:47:00 PM \| Browse: 1238 \| Download: 1374